GSK1292263

0 reviews Write a review

Product Code: 3160
Availability: In Stock

$473.00

MG Options

Qty

GSK1292263 is a novel GPR119 agonist, showing potential for the treatment of type 2 diabetes. Phase 2.

Chemical Name : 5-((1-(3-isopropyl-1,2,4-oxadiazol-5-yl)piperidin-4-yl)methoxy)-2-(4-(methylsulfonyl)phenyl)pyridine

Biological Activity:
Biological Activity	GSK1292263 is a novel GPR119 agonist, showing potential for the treatment of type 2 diabetes. Phase 2.
Technical Data:
M.W.	456.56
Formula:	C<sub>23</sub>H<sub>28</sub>N<sub>4</sub>O<sub>4</sub>S
Solubility:	DMSO
Purity:	98%
Storage:	-20℃
CAS No:	1032823-75-8
References:
References	Zhu X, et al. Eur J Med Chem, 2011, 46(7), 2901-2907. Brown KK, et al. Diabetes, 2010, 59(Suppl. 1), Abst 1733-P.

Write a review

Your Name

Your Review Note: HTML is not translated!

Rating Bad Good

Continue

About HDH PHARMA

At HDH Pharma, we are committed to offering our clients the highest quality research services with the most convenient and effective communications from both US and Indian operations. Clients in the Americas and Europe can pick up the phone and speak directly with our scientists in the US. Clients in Asia can receive the same rapid response from our scientists in India. HDH’s hybrid operation is designed with our client’s operational needs in mind.

GSK1292263

Write a review

About HDH PHARMA

Information

Extras

My Account